BioCryst Pharmaceuticals Inc (BCRX) — Financial Flexibility Index
BioCryst Pharmaceuticals Inc (BCRX) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-61.73 Million (operating CF $-62.14 Million minus capex $403.00K) represents 0% of total liabilities ($1.02 Billion). Check BCRX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioCryst Pharmaceuticals Inc Financial Flexibility Index (1994–2025)
Historical Financial Flexibility Index trend for BioCryst Pharmaceuticals Inc across 32 annual periods. See how liquid is BioCryst Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BioCryst Pharmaceuticals Inc (1994–2025)
Year-by-year free cash flow to debt coverage for BioCryst Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of BioCryst Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.52x | $332.35 Million | $329.88 Million | $633.31 Million | ▲ +1096.4% |
| 2024 | -0.05x | $-50.90 Million | $-52.02 Million | $966.35 Million | ▲ +44.9% |
| 2023 | -0.10x | $-92.97 Million | $-95.14 Million | $972.49 Million | ▲ +49.7% |
| 2022 | -0.19x | $-160.50 Million | $-161.85 Million | $844.60 Million | ▲ +5.5% |
| 2021 | -0.20x | $-139.77 Million | $-142.16 Million | $695.14 Million | ▲ +47.9% |
| 2020 | -0.39x | $-136.70 Million | $-137.22 Million | $353.98 Million | ▲ +40.7% |
| 2019 | -0.65x | $-89.24 Million | $-89.58 Million | $137.03 Million | ▲ +31.1% |
| 2018 | -0.94x | $-92.20 Million | $-92.56 Million | $97.61 Million | ▼ -118.7% |
| 2017 | -0.43x | $-40.81 Million | $-41.14 Million | $94.49 Million | ▲ +20.8% |
| 2016 | -0.55x | $-48.16 Million | $-53.44 Million | $88.27 Million | ▼ -424.4% |
| 2015 | -0.10x | $-7.99 Million | $-13.12 Million | $76.83 Million | ▲ +83.4% |
| 2014 | -0.63x | $-38.45 Million | $-38.55 Million | $61.24 Million | ▼ -18.4% |
| 2013 | -0.53x | $-26.50 Million | $-26.53 Million | $49.99 Million | ▲ +17.7% |
| 2012 | -0.64x | $-37.28 Million | $-37.40 Million | $57.89 Million | ▼ -34.8% |
| 2011 | -0.48x | $-32.20 Million | $-32.25 Million | $67.40 Million | ▲ +25.6% |
| 2010 | -0.64x | $-28.23 Million | $-28.55 Million | $43.94 Million | ▼ -130.1% |
| 2009 | -0.28x | $-15.61 Million | $-16.22 Million | $55.92 Million | ▲ +45.7% |
| 2008 | -0.51x | $-19.66 Million | $-20.87 Million | $38.27 Million | ▼ -101.2% |
| 2007 | 42.65x | $3.32 Billion | $-25.00 Million | $77.81 Million | ▲ +14860.5% |
| 2006 | -0.29x | $-13.68 Million | $-15.21 Million | $47.33 Million | ▲ +48.4% |
| 2005 | -0.56x | $-22.85 Million | $-23.35 Million | $40.81 Million | ▲ +90.2% |
| 2004 | -5.70x | $-17.88 Million | $-18.15 Million | $3.13 Million | ▲ +15.6% |
| 2003 | -6.76x | $-11.14 Million | $-11.20 Million | $1.65 Million | ▲ +50.3% |
| 2002 | -13.61x | $-15.96 Million | $-16.36 Million | $1.17 Million | ▼ -311.2% |
| 2001 | -3.31x | $-7.55 Million | $-10.16 Million | $2.28 Million | ▼ -6707.2% |
| 2000 | -0.05x | $-454.34K | $-3.18 Million | $9.35 Million | ▲ +97.5% |
| 1999 | -1.95x | $-3.90 Million | $-4.90 Million | $2.00 Million | ▲ +28.2% |
| 1998 | -2.71x | $-3.80 Million | $-4.20 Million | $1.40 Million | ▲ +64.6% |
| 1997 | -7.67x | $-9.20 Million | $-10.30 Million | $1.20 Million | ▼ -100.5% |
| 1996 | -3.82x | $-6.50 Million | $-6.80 Million | $1.70 Million | ▲ +8.2% |
| 1995 | -4.17x | $-7.50 Million | $-7.70 Million | $1.80 Million | ▼ -9.3% |
| 1994 | -3.81x | $-6.10 Million | $-6.50 Million | $1.60 Million | — |